am 251 and am 281
am 251 has been researched along with am 281 in 10 studies
Research
Studies (10)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 5 (50.00) | 29.6817 |
2010's | 4 (40.00) | 24.3611 |
2020's | 1 (10.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Caulder, T; Hoffman, AF; Horti, AG; Katoch-Rouse, R; Mukhin, AG; Pavlova, OA | 1 |
Drmota, T; Elebring, T; Greasley, PJ; Hermansson, NO; Hjorth, S; Larsson, N; Leonova, J; Nilsson, K; Ryberg, E; Sjögren, S | 1 |
Arthur, S; Balenga, NA; Henstridge, CM; Irving, AJ; Kargl, JK; Kostenis, E; Martini, L; Penman, J; Platzer, W; Schröder, R; Waldhoer, M; Whistler, JL | 1 |
Cheng, JS; Chou, KJ; Fang, HC; Jan, CR; Law, YP; Lee, KC; Su, W; Tseng, LL; Wang, JL | 1 |
Cole, RB; Ma, P; Wang, G; Wang, W; Zhang, Q | 1 |
Pertwee, RG | 1 |
Chen, W; Lao, L; Marvizón, JC; Zhang, G | 1 |
Atkinson, HC; Castrique, ES; Kershaw, YM; Leggett, JD; Lightman, SL; Wood, SA | 1 |
Brents, LK; Fantegrossi, WE; Franks, LN; Prather, PL; Rajasekaran, M; Seely, KA; Zimmerman, SM | 1 |
Dong, X; Jiang, J; Jiang, Y; Liu, X; Ye, Y; Zhang, D; Zhu, R | 1 |
Reviews
1 review(s) available for am 251 and am 281
Article | Year |
---|---|
Inverse agonism and neutral antagonism at cannabinoid CB1 receptors.
Topics: Animals; Benzofurans; Cannabinoids; Morpholines; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Rimonabant | 2005 |
Other Studies
9 other study(ies) available for am 251 and am 281
Article | Year |
---|---|
Synthesis, structure-activity relationship, and evaluation of SR141716 analogues: development of central cannabinoid receptor ligands with lower lipophilicity.
Topics: Animals; Benzoxazines; Cannabinoids; Cerebellum; In Vitro Techniques; Ligands; Membrane Potentials; Morpholines; Naphthalenes; Nucleus Accumbens; Piperidines; Pyrazoles; Radioligand Assay; Rats; Receptors, Cannabinoid; Receptors, Drug; Rimonabant; Structure-Activity Relationship; Tomography, Emission-Computed | 2003 |
The orphan receptor GPR55 is a novel cannabinoid receptor.
Topics: Amino Acid Sequence; Animals; Arachidonic Acids; Binding Sites; Binding, Competitive; Cannabidiol; Cannabinoids; Cell Line; Cloning, Molecular; Cyclohexanols; Down-Regulation; Endocannabinoids; Guanosine 5'-O-(3-Thiotriphosphate); Humans; Ligands; Mice; Molecular Sequence Data; Organ Specificity; Polymerase Chain Reaction; Polyunsaturated Alkamides; Rats; Receptors, Cannabinoid; Receptors, G-Protein-Coupled; RNA, Messenger; Signal Transduction; Structure-Activity Relationship | 2007 |
GPR55 ligands promote receptor coupling to multiple signalling pathways.
Topics: Biological Assay; Cannabinoids; Cell Line, Transformed; Endocytosis; Humans; Ligands; Lysophospholipids; Morpholines; Piperidines; Pyrazoles; Receptors, Cannabinoid; Receptors, G-Protein-Coupled; Rimonabant; Signal Transduction | 2010 |
CP55,940 increases intracellular Ca2+ levels in Madin-Darby canine kidney cells.
Topics: Animals; Calcium; Cannabinoids; Cell Line; Cyclohexanols; Dogs; Estrenes; Extracellular Space; Indicators and Reagents; Inositol 1,4,5-Trisphosphate; Kidney; Morpholines; Piperidines; Pyrazoles; Pyrrolidinones; Receptors, Cannabinoid; Receptors, Drug | 2001 |
In vitro metabolism of diarylpyrazoles, a novel group of cannabinoid receptor ligands.
Topics: Animals; Chromatography, High Pressure Liquid; In Vitro Techniques; Magnetic Resonance Spectroscopy; Mass Spectrometry; Microsomes, Liver; Morpholines; Piperidines; Pyrazoles; Rats; Receptors, Cannabinoid; Rimonabant | 2005 |
Cannabinoid CB1 receptor facilitation of substance P release in the rat spinal cord, measured as neurokinin 1 receptor internalization.
Topics: Animals; Capsaicin; Electric Stimulation; GABA-B Receptor Antagonists; Injections, Spinal; Male; Morpholines; Neurons; Pain; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Receptors, G-Protein-Coupled; Receptors, Neurokinin-1; Receptors, Opioid, mu; Sensory System Agents; Spinal Cord; Spinal Nerve Roots; Substance P; TRPV Cation Channels | 2010 |
Regulation of the hypothalamic-pituitary-adrenal axis circadian rhythm by endocannabinoids is sexually diergic.
Topics: Adrenocorticotropic Hormone; Animals; Cannabinoid Receptor Modulators; Circadian Rhythm; Corticosterone; Endocannabinoids; Female; Hormone Antagonists; Hypothalamo-Hypophyseal System; Male; Morpholines; Piperidines; Pituitary-Adrenal System; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Sex Characteristics | 2010 |
AM-251 and rimonabant act as direct antagonists at mu-opioid receptors: implications for opioid/cannabinoid interaction studies.
Topics: Analgesics, Non-Narcotic; Analgesics, Opioid; Animals; Binding, Competitive; Cannabinoid Receptor Agonists; CHO Cells; Cricetinae; Cricetulus; Drug Inverse Agonism; Humans; Kinetics; Mice; Mice, Inbred Strains; Morpholines; Narcotic Antagonists; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Receptors, Opioid, mu; Recombinant Proteins; Rimonabant | 2012 |
Cannabinoid 1 Receptor Antagonists Play a Neuroprotective Role in Chronic Alcoholic Hippocampal Injury Related to Pyroptosis Pathway.
Topics: Alcohol-Induced Disorders, Nervous System; Animals; Cannabinoid Receptor Agonists; Cannabinoid Receptor Antagonists; Caspase 1; Caspase Inhibitors; Central Nervous System Depressants; Dipeptides; Ethanol; Hippocampus; Inflammation; Interleukin-18; Interleukin-1beta; Intracellular Signaling Peptides and Proteins; Mice; Morpholines; Neuroprotective Agents; Neurotoxicity Syndromes; NLR Family, Pyrin Domain-Containing 3 Protein; para-Aminobenzoates; Phosphate-Binding Proteins; Piperidines; Pyrazoles; Pyroptosis; Receptor, Cannabinoid, CB1 | 2020 |